The post Coinbase Shiba Inu Whale Breaks Yearly Silence With 53,591,805,991 SHIB Transfer appeared on BitcoinEthereumNews.com. A Coinbase-linked Shiba Inu whaleThe post Coinbase Shiba Inu Whale Breaks Yearly Silence With 53,591,805,991 SHIB Transfer appeared on BitcoinEthereumNews.com. A Coinbase-linked Shiba Inu whale

Coinbase Shiba Inu Whale Breaks Yearly Silence With 53,591,805,991 SHIB Transfer

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

A Coinbase-linked Shiba Inu whale has reappeared on-chain after a full year of silence, and the numbers make it impossible to ignore. According to Arkham, wallet “0x1b1” received 53,591,805,991 SHIB from a Coinbase hot wallet about 20 hours ago, a transfer valued at around $415,000 right now.

What is most interesting is that this was not a new accumulation story starting from zero, and the history matters more than the headline number.

The same address interacted with Coinbase deposits multiple times three years ago, moving blocks ranging from 1.8 billion to 109.4 billion SHIB during earlier cycles. One year ago, the wallet sent out 43.6 billion SHIB and 9.1 billion SHIB to Coinbase deposit addresses, then went dark. No visible on-chain activity followed until now.

Source: Arkham

At the same time, the Shiba Inu coin has spent 2025 unwinding a long drawdown rather than building an upside structure to say the least. The year opened above $0.00002, then sold off aggressively through January and February, pushing the price into the $0.000012-$0.000015 range by spring. 

Has worst already happened to Shiba Inu coin?

The decisive breakdown finally came in October, when SHIB lost $0.00001 in a single expansion move and never reclaimed it. Since then, the price has compressed lower, trading around $0.0000080, near the bottom of the yearly range. 

You Might Also Like

Against this context, the Coinbase-linked whale is waking up to exhaustion rather than strength. After months of price decline and waning participation, this phase has historically preceded either aggressive redistribution or the kind of positioning that only occurs when larger players believe the worst damage has already been priced in.

Source: https://u.today/coinbase-shiba-inu-whale-breaks-yearly-silence-with-53591805991-shib-transfer

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09